Advertisement

Opioid prescribing after oocyte-retrieval: a time for caution

      In this issue of Fertility and Sterility, Bortoletto et al. (
      • Bortoletto P.
      • Prabhu M.
      • Garry E.M.
      • Huybrechts K.F.
      • Anchan R.M.
      • Bateman B.T.
      Opioid dispensing patterns after oocyte retrieval.
      ) present data on opioid dispensing after oocyte retrieval that should be eye opening to anyone who has been paying attention to the current opioid epidemic. Overprescribing of opioids leads to increased risk to not only the person to whom the opioids are prescribed but also to the community at large. As the authors point out in the introduction, most people developing a heroin use disorder (80%) began with misuse of prescription opioids. In addition, many people prescribed medication after a procedure do not use all their medications, and do not dispose of the leftovers properly, which leaves them available for misuse by family and friends.
      To read this article in full you will need to make a payment

      References

        • Bortoletto P.
        • Prabhu M.
        • Garry E.M.
        • Huybrechts K.F.
        • Anchan R.M.
        • Bateman B.T.
        Opioid dispensing patterns after oocyte retrieval.
        Fertil Steril. 2018; 110: 905-909
        • Bateman B.T.
        • Cole N.M.
        • Maeda A.
        • Burns S.M.
        • Houle T.T.
        • Huybrechts K.F.
        • et al.
        Patterns of opioid prescription and use after cesarean delivery.
        Obstet Gynecol. 2017; 130: 29-35
        • Centers for Disease Control and Prevention
        CDC Guideline for prescribing opioids for chronic pain.
        (Available at:)
        • Wright T.E.
        Screening, brief intervention, and referral to treatment for opioid and other substance use during infertility treatment.
        Fertil Steril. 2017; 108: 214-221
        • Prabhu M.
        • McQuaid-Hanson E.
        • Hopp S.
        • Burns S.M.
        • Leffert L.R.
        • Landau R.
        • et al.
        A shared decision-making intervention to guide opioid prescribing after cesarean delivery.
        Obstet Gynecol. 2017; 130: 42-46

      Linked Article